Bill Schnoor > Goodwin > London, England > Lawyer Profile
Goodwin Offices

Sancroft, 10-15 Newgate Street
London
EC1A 7AZ
England
- Firm Profile
- Go to...
Bill Schnoor

Position
Partner
Career
Bill Schnoor is a partner in and former co-chair of the firm’s Technology and Life Sciences groups. He works in all areas of corporate, securities and partnership laws, with a primary focus on advising high-growth technology and life sciences companies. He joined Goodwin in 2005, after a 21-year career with Testa, Hurwitz & Thibeault, LLP, and quickly became co-chair of Goodwin’s technology and life sciences practices. Under his leadership the Technology and Life Sciences group expanded successfully into northern California, becoming one of the top-ranked practices in that market. In 2018, Bill relocated to London to lead the expansion of Goodwin’s Technology and Life Sciences practices in the United Kingdom and across continental Europe. He rejoined the firm’s Boston office in July 2020 but continues to work actively with clients in the United Kingdom, across Europe and in Israel, as well as in the United States.
Education
JD, 1983, Yale Law School / BA, 1980, Yale University (summa cum laude)
Lawyer Rankings
United States > M&A/corporate and commercial > Venture capital and emerging companies
(Hall of Fame)Goodwin’s signature technology expertise is a big draw for start-ups, while it also leverages a dominant life sciences offering that ‘provides everything a biotech company could need’. Alongside its company-side credentials, the group maintains close links with investors and it routinely advises venture capital funds on fundraisings, investments, and exits. From Boston, Mitch Bloom steers the life science practice and specializes in advising public and private life sciences companies and investors on financings, M&A, and public offerings. The technology and emerging companies team is co-led by Boston-based duo John Egan and Kenneth Gordon, together with Silicon Valley’s Craig Schmitz , all of whom act for an array of start-ups, growth companies, and investors. Other contacts in Boston include Bill Schnoor, who, as previous head of the London office, is recommended for cross-border transactions involving the technology and life sciences sectors; Danielle Lauzon, who is recognized for her cutting-edge expertise in the life sciences field; and William Collins, who excels in matters involving the biotechnology, pharmaceuticals, and medical devices spheres. In Silicon Valley, Caine Moss focuses on supporting software, AI, internet, and financial services companies through all stages of their growth.
Top Tier Firm Rankings
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Investment fund formation and management > Real estate funds
- Corporate and commercial > Venture capital
Firm Rankings
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Investment fund formation and management > Private funds
- Real estate > Commercial property: investment
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- Industry focus > Hospitality and leisure
- Industry focus > Life sciences and healthcare
- Finance > Acquisition finance
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Real estate > Property finance
- Dispute resolution > Commercial litigation: premium
- Employment > Employers
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > Equity capital markets – small-mid cap
- Corporate and commercial > EU and competition
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)